Consensus Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
268.9 ^USD	+2.35%		+0.62%	-6.63%

Apr. 19	Wall Street: tech and SOXX in free fall this week	CF
Apr. 17	UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	MT

Evolution of the average Target Price on Amgen Inc.

Price target over the last 5 years

History of analyst recommendation changes

bb1ee61a778a568e0ce93f5f2f9591b2.XyZKK9JXcRyW5z0uSM-4a6jfB1v5ziuhAChWJPH5rbE.PncSXKA8I27-jhAeHbX6Xp_qKi6-oU7uYxg_SpeWlNNqcjpkiic2SNqzcA~6b3bb2f7d3a78aaa7df9e84f8aeaf002

Analyst Recommendations on Amgen Inc.

UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	Apr. 17	MT
TD Cowen Cuts Price Target on Amgen to $360 From $370, Buy Rating Kept	Apr. 15	MT
Goldman Sachs Adjusts Amgen Price Target to $359 From $361, Maintains Buy Rating	Apr. 15	MT
BMO Lowers Price Target on Amgen to $336 From $343	Apr. 12	MT
Morgan Stanley Cuts Price Target on Amgen to $271 From $278, Keeps Equalweight Rating	Apr. 09	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
Oppenheimer Adjusts Amgen Price Target to $380 From $350, Maintains Outperform Rating	Feb. 07	MT
TD Cowen Adjusts Amgen Price Target to $370 From $336, Maintains Outperform Rating	Feb. 07	MT
Leerink Partners Downgrades Amgen to Market Perform From Outperform, Adjusts Price Target to $324 From $318	Feb. 07	MT
Baird Adjusts Amgen Price Target to $215 From $185, Maintains Underperform Rating	Feb. 07	MT
Goldman Sachs Adjusts Amgen Price Target to $350 From $313, Maintains Buy Rating	Feb. 07	MT
Morgan Stanley Trims Price Target on Amgen to $278 From $281 After Higher-Than-Expected Q4 2023 Results, Keeps Equalweight Rating	Feb. 07	MT
RBC Boosts Price Target on Amgen to $329 From $303 After Q4 Beats, Notes 'Positive' Pipeline Posture; Keeps Outperform Rating	Feb. 07	MT
That's good enough for investors	Feb. 06
MORNING BID AMERICAS-Rates rebound cools, China commands rally	Feb. 06	RE
Deutsche Bank Adjusts Amgen Price Target to $285 From $240, Maintains Hold Rating	Feb. 02	MT
UBS Trims Amgen Price Target to $314 From $315, Maintains Neutral Rating	Jan. 29	MT
RBC Lifts Price Target on Amgen to $303 From $300, Keeps Outperform Rating	Jan. 03	MT
Daiwa Securities Upgrades Amgen to Buy From Neutral, Price Target is $320	Dec. 21	MT
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments...	Dec. 21
Wall Street ends higher as rate-cut fever lingers	Dec. 19	RE
Wall Street advances as rate-cut fever lingers	Dec. 19	RE
Wall St climbs as rate-cut optimism lingers	Dec. 19	RE
Investors got more clues that rate cuts are imminent	Dec. 19

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

268.9 USD

Average target price

300.3 USD

Spread / Average Target

+11.65%

High Price Target

380 USD

Spread / Highest target

+41.30%

Low Price Target

170 USD

Spread / Lowest Target

-36.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Amgen Inc.

UBS
TD Cowen
Goldman Sachs
BMO Capital
Morgan Stanley
Oppenheimer
Leerink Partners
Baird
RBC Capital Markets
Deutsche Bank Securities
Daiwa Securities
Truist Securities
Argus
HSBC
Jefferies & Co.
Mizuho Securities
Credit Suisse
Barclays
DA Davidson
Piper Sandler
Wells Fargo Securities
SVB Securities LLC
Cowen
Atlantic Equities
BofA Securities
SVB Leerink
JPMORGAN	Cory Kasimov
RBC	Kennen Mackay

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar